Mount Sinai Centralizes Oversight of Its Growing AI Portfolio

Mount Sinai Health System in New York City will evaluate Signal 1's AI Management Platform, known as AIMS, to bring all of its artificial intelligence tools under one governance roof, according to Becker's Hospital Review. The platform tracks every AI model in operation or under evaluation, standardizes intake and approval workflows, and automates monitoring and reporting.

The move reflects a broader shift among large health systems. As hospitals deploy more AI for clinical decisions, documentation, and operations, leaders are realizing that scattered, unmonitored models pose real risks. Performance can drift over time, and without continuous tracking, a tool that worked at launch may quietly degrade or introduce bias. Centralized oversight is becoming the answer.

For Mount Sinai, a single system replaces ad hoc reviews with a repeatable process, giving compliance, IT, and clinical teams shared visibility into what is running and how well it works. Expect more systems to adopt similar AI governance platforms as regulators and boards demand accountability for algorithms touching patient care.